KW-2478

DRUG2 trials

Sponsors

Kyowa Kirin Co., Ltd.

Conditions

B-cell Non-Hodgkin's LymphomaChronic Lymphocytic LeukaemiaMultiple Myeloma

Phase 1

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

CompletedNCT00457782

Kyowa Kirin Co., Ltd.B-cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukaemia, Multiple Myeloma

Start: 2007-04-30End: 2011-01-31Updated: 2024-04-25

A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

CompletedNCT01063907

Kyowa Kirin Co., Ltd.Multiple Myeloma

Start: 2010-03-31End: 2013-11-30Updated: 2024-04-25